drugset
drugset / Trial / NCT03505346

68 Ga-NODAGA-E[c(RGDγK)]2: Positron Emission Tomography Tracer for Imaging of Angiogenesis in Ischemic Heart Disease

NCT03505346 ↗

Phase 2 Unknown 42 enrolled Rigshospitalet, Denmark
Non-randomizedParallel-groupOpen-labelPrevention

Summary

The aim is to examine the expression of αvβ3 integrin using a novel selective radiotracer in patients with chronich ischemic heart disease and investigate if it is a suitable tool for predicting myocardial recovery and thus prognosis after intervention.

Timeline

Start
2024-01-01
Primary completion
2025-12-01
Completion
2025-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject 68Ga-NODAGA-E[c(RGDyK)]2 Diagnostic / imaging agent 200 mbq Intravenous

Indications

myocardial ischemia